» Articles » PMID: 31541215

The Impact of Artificial Intelligence in the Diagnosis and Management of Glaucoma

Overview
Journal Eye (Lond)
Specialty Ophthalmology
Date 2019 Sep 22
PMID 31541215
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Deep learning (DL) is a subset of artificial intelligence (AI), which uses multilayer neural networks modelled after the mammalian visual cortex capable of synthesizing images in ways that will transform the field of glaucoma. Autonomous DL algorithms are capable of maximizing information embedded in digital fundus photographs and ocular coherence tomographs to outperform ophthalmologists in disease detection. Other unsupervised algorithms such as principal component analysis (axis learning) and archetypal analysis (corner learning) facilitate visual field interpretation and show great promise to detect functional glaucoma progression and differentiate it from non-glaucomatous changes when compared with conventional software packages. Forecasting tools such as the Kalman filter may revolutionize glaucoma management by accounting for a host of factors to set target intraocular pressure goals that preserve vision. Activation maps generated from DL algorithms that process glaucoma data have the potential to efficiently direct our attention to critical data elements embedded in high throughput data and enhance our understanding of the glaucomatous process. It is hoped that AI will realize more accurate assessment of the copious data encountered in glaucoma management, improving our understanding of the disease, preserving vision, and serving to enhance the deep bonds that patients develop with their treating physicians.

Citing Articles

Validation of a Novel Low-Cost Glaucoma Risk Calculator for Community-Based Screening in High-Risk Populations.

Grimes K, Madu C, Carrington C, Laroche D Clin Ophthalmol. 2025; 19:357-369.

PMID: 39926312 PMC: 11804874. DOI: 10.2147/OPTH.S500509.


Glaucoma detection and staging from visual field images using machine learning techniques.

Akter N, Gordon J, Li S, Poon M, Perry S, Fletcher J PLoS One. 2025; 20(1):e0316919.

PMID: 39823435 PMC: 11741594. DOI: 10.1371/journal.pone.0316919.


Automated analysis for glaucoma screening of retinal videos acquired with smartphone-based ophthalmoscope.

Scarpa F, Berto A, Tsiknakis N, Manikis G, Fotiadis D, Marias K Heliyon. 2025; 10(14):e34308.

PMID: 39816342 PMC: 11734129. DOI: 10.1016/j.heliyon.2024.e34308.


Novel Approaches for the Early Detection of Glaucoma Using Artificial Intelligence.

Zeppieri M, Gardini L, Culiersi C, Fontana L, Musa M, DEsposito F Life (Basel). 2024; 14(11).

PMID: 39598184 PMC: 11595922. DOI: 10.3390/life14111386.


Automated classification of angle-closure mechanisms based on anterior segment optical coherence tomography images via deep learning.

Zhang Y, Zhang X, Zhang Q, Lv B, Hu M, Lv C Heliyon. 2024; 10(15):e35236.

PMID: 39166052 PMC: 11334645. DOI: 10.1016/j.heliyon.2024.e35236.


References
1.
DeVries P, Viegas F, Wattenberg M, Meade B . Deep learning of aftershock patterns following large earthquakes. Nature. 2018; 560(7720):632-634. DOI: 10.1038/s41586-018-0438-y. View

2.
Chen H, Engkvist O, Wang Y, Olivecrona M, Blaschke T . The rise of deep learning in drug discovery. Drug Discov Today. 2018; 23(6):1241-1250. DOI: 10.1016/j.drudis.2018.01.039. View

3.
Ho K, Speier W, El-Saden S, Arnold C . Classifying Acute Ischemic Stroke Onset Time using Deep Imaging Features. AMIA Annu Symp Proc. 2018; 2017:892-901. PMC: 5977679. View

4.
Slivitskii M . [Absorption of volatile fatty acid salt in the abomasum in sheep]. Fiziol Zh. 1970; 16(3):374-8. View

5.
Asaoka R, Murata H, Hirasawa K, Fujino Y, Matsuura M, Miki A . Using Deep Learning and Transfer Learning to Accurately Diagnose Early-Onset Glaucoma From Macular Optical Coherence Tomography Images. Am J Ophthalmol. 2018; 198:136-145. DOI: 10.1016/j.ajo.2018.10.007. View